One Drop Launches Global Commercial Partnership with Bayer
Vinson & Elkins advised One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, in connection with a $40 million Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world.
Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease and women’s health.
The V&E corporate team was led by partner Paul Tobias and counsel Andy Smetana with assistance from associates Ben Cukerbaum and Vaughn Miller. Also advising was partner Damara Chambers.
For more information, please speak with our media contacts.